Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Rachael Ann VaubelRahul KumarTaylor M WeiskittelSarah JenkinsSurendra DasariJoon H UhmDaniel H LachancePaul D BrownJamie J Van GompelRobert B JenkinsBenjamin R KippWilliam R SukovCaterina GianniniDerek R JohnsonAditya RaghunathanPublished in: Neuro-oncology advances (2023)
CNVs are strong predictors of RFS in grade 2 meningiomas following GTR. Our study supports incorporation of CNV profiling into clinical evaluation to better guide postoperative patient management, which can be readily implemented using existing, clinically validated technologies.